COMBINATION OF MOLECULAR IODINE AND ANTHRACYCLINES FOR HUMAN USE FOR THE PREVENTION AND TREATMENT OF IODINE-CAPTURING CHEMICALLY-RESISTANT CANCERS

The present invention relates to a pharmaceutical combination that can be used in the prevention and treatment of iodine-capturing chemically-resistant cancers, said combination comprising a composition of molecular iodine and anthracylines for human use. The molecular iodine composition can be admi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CARMEN YOLANDA ACEVES VELASCO, ROCÍO BRENDA ANGUIANO SERRANO
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to a pharmaceutical combination that can be used in the prevention and treatment of iodine-capturing chemically-resistant cancers, said combination comprising a composition of molecular iodine and anthracylines for human use. The molecular iodine composition can be administered orally or topically and is administered in conjunction with chemotherapy using anthracyclines, thereby preventing the cancerous cell from developing resistance to the anthracyclines by inhibiting the expression of the anti-apoptotic proteins. The molecular iodine composition is administered continuously before, sequentially, conjointly or simultaneously with the chemotherapy using anthracyclines. La presente invención se refiere a una combinación farmacéutica útil en a la prevención y tratamiento de cánceres quimiorresistentes captadores de yodo que comprende una composición de yodo molecular y antraciclinas de uso humano. La composición de yodo molecular es de administración oral o tópica y se administra en coadyuvancia con un tratamiento quimioterapéutico con antraciclinas, evitando que la célula cancerosa se vuelva resistente a las antraciclinas mediante la inhibición de la expresión de proteínas antiapoptóticas. La composición de yodo molecular se administra de forma continua previamente, secuencialmente, conjuntamente o simultáneamente al tratamiento quimioterapéutico con antraciclinas.